Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cell Reports|December 21, 2021
Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronavirusesPaul R Wratil, Niklas A Schmacke, Burak Karakoc, et al.
Vaccines|November 26, 2024
STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver DiseaseSimon Woelfel, Daniel Junker, Irina Bergamin, et al.
Scientific Reports|November 18, 2022
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinationsHenning Jacobsen, Monika Strengert, Henrike Maaß, et al.
Ebiomedicine|September 26, 2022
Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort studyAnneke Haddad, Aleš Janda, Hanna Renk, et al.
Frontiers in Immunology|March 7, 2022
Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in GermanyAlex Dulovic, Barbora Kessel, Manuela Harries, et al.
The Journal of Clinical Investigation|October 27, 2022
Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacityChristian Meyer Zu Natrup, Alina Tscherne, Christine Dahlke, et al.
Nature Communications|February 20, 2021
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivityMatthias Becker, Monika Strengert, Daniel Junker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2022
Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron VariantsDaniel Junker, Matthias Becker, Teresa R Wagner, et al.
American Journal of Respiratory and Critical Care Medicine|August 4, 2022
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19Tobias Sinnberg, Christa Lichtensteiger, Omar Hasan Ali, et al.
Nature Communications|January 11, 2022
Robust and durable serological response following pediatric SARS-CoV-2 infectionHanna Renk, Alex Dulovic, Alina Seidel, et al.
Pageof 4